ARCHIVES

In Brief: Hong to Retire After 30 Years at MD Anderson

This article is from The Cancer Letter archive.

Vol. 40 No. 07 | February 14, 2014

Download PDF Visit The Full Archive

Related Articles

Also in this 12-page issue: Senate report endorses NCI’s 2015 goal.

July 22, 2005

The Cancer Letter Marks 25th Anniversary

December 18, 1998

US Oncology Begins Trial Of Taxotere And Xeloda

September 27, 2002

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

February 24, 2006

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

September 28, 2001

Long-Term Results Find Cisplatin Improves Survival

May 25, 2007